Colour vision testing for diabetic retinopathy: A systematic review of diagnostic accuracy and economic evaluation

Health Technology Assessment

Volumn 13, Issue 60, 2009, Pages 1-136

  Rodgers, Mark ^a   Hodges, Rebecca ^b   Hawkins, James ^b   Hollingworth, Will ^b   Duffy, Steven ^a   McKibbin, Martin ^c   Mansfield, Michael ^d   Harbord, Roger ^b   Sterne, Jonathan ^b   Glasziou, Paul ^e   Whiting, Penny ^b   Westwood, Marie ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLOR VISION TEST; COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ECONOMIC EVALUATION; HEALTH PROGRAM; HUMAN; PHOTOGRAPHY; RETINA IMAGE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLOR VISION DEFECTS; DIABETIC RETINOPATHY; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 74849135543     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13600     Document Type: Review

References (94)

1. Kohner EM, Porta M. Protocols for screening and treatment of diabetic retinopathy in Europe. Eur J Ophthalmol 1991;1:45-54.
2. Klein R, Meuer SM, Moss SE, Klein BE. Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol 1995;113:1386-91.
3. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(Suppl. 5):766-85.
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
5. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
6. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
7. National Institute for Clinical Excellence. Inherited Clinical Guideline E. Management of type 2 diabetes: retinopathy - screening and early management. London: National Institute for Clinical Excellence; 2002.
8. Diabetes Control and Complications Trial Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874-86.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
10. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
11. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
12. Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12:485-7.
13. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996;19:1243-8.
14. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report No. 18. Invest Ophthalmol Vis Sci 1998;39:233-52.
15. Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990;13:34-40.
16. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006;6:58.
17. Rhatigan MC, Leese GP, Ellis J, Ellingford A, Morris AD, Newton RW, et al. Blindness in patients with diabetes who have been screened for eye disease. Eye 1999;13:166-9.
18. Trautner C, Icks A, Haastert B, Plum F, Berger M. Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997;20:1147-53.
19. Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW. Incidence of blindness due to diabetic eye disease in Fife 1990-9. Br J Ophthalmol 2001;85:354-6.
20. Hutchinson A, McIntosh A, Peters J, O'Keeffe C, Khunti K, Baker R, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med 2000;17:495-506.
21. British Diabetic Association. Retinal photography screening for diabetic eye disease: a British Diabetic Association Report. London: British Diabetic Association; 1997.
22. Arun CS, Ngugi N, Lovelock L, Taylor R. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med 2003;20:186-90.
23. Scottish Intercollegiate Guidelines Network. Management of diabetes. A national clinical guideline. SIGN Clinical Guidelines 55. Edinburgh: Scottish Intercollegiate Guidelines Network; 2001.
24. National Institute for Clinical Excellence. Diagnosis and management of type 1 diabetes in children, young people and adults. Clinical Guideline 15. Developed by the National Collaborating Centre for Women's and Children's Health and the National Collaborating Centre for Chronic Conditions. London: National Institute for Clinical Excellence; 2004.
25. Department of Health. National service framework for diabetes. London: Department of Health; 2001.
26. Department of Health. Diabetic retinopathy screening statement. London; Department of Health; 2008.
27. Birch J. Diagnosis of defective colour vision. Oxford: Oxford University Press; 1993.
28. Sharp PF, Olson J, Strachan F, Hipwell J, Ludbrook A, O'Donnell M. The value of digital imaging in diabetic retinopathy. Health Technol Assess 2003;7:1-132.
29. Sculpher MJ, Buxton MJ, Ferguson BA, Spiegelhalter DJ, Kirby AJ. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1992;1:39-51.
30. Buxton MJ, Sculpher MJ, Ferguson BA, Humphreys JE, Altman JF, Spiegelhalter DJ, et al. Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med 1991;8:371-7.
31. Ong GL, Ripley LG, Newsom RS, Cooper M, Casswell AG. Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test. Am J Ophthalmol 2004;137:445-52.
32. Maár N, Tittl M, Stur M, Zajic B, Reitner A. A new colour vision arrangement test to detect functional changes in diabetic macular oedema. Br J Ophthalmol 2001;85:47-51.
33. Centre for Reviews and Dissemination. Systematic reviews of clinical tests. Systematic reviews: CRD's guidance for undertaking reviews in health care. CRD Report No. 4. 3rd edn. York: University of York; 2008.
34. Cochrane Diagnostic Test Accuracy Working Group. Cochrane handbook for diagnostic test accuracy reviews. (forthcoming)
35. Whiting P, Rutjes AWS, Reitsma JB, Bossuyt PMM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
36. Aspinall PA, Kinnear PR, Duncan LJ, Clarke BF. Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care 1983;6:144-8.
37. Ayed S, Jeddi A, Kallal Z. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia]. J Fr Opthalmol 1990;13:506-10.
38. Barton FB, Bresnick GH, Garcia CA, Benson W, Knatterud GL. ETDRS baseline color vision test results. Invest Ophthalmol Vis Sci 1987;28(Suppl. 3):244.
39. Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. Am J Ophthalmol 1999;128:612-17.
40. Green FD, Ghafour IM, Allan D, Barrie T, McClure E, Foulds WS. Colour vision of diabetics. Br J Ophthalmol 1985;69:533-6.
41. Greenstein V, Sarter B, Hood D, Noble K, Carr R. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1990;31:1008-14.
42. Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic and Physiol Opt 1998;18:3-12.
43. Jeddi A, Ben Osman N, Daghfous F, Kaoueche M, Baccar M, Gaigi S, et al. [Methods for screening and surveillance of diabetic retinopathy]. J Fr Opthalmol 1994;17:769-73.
44. Lombrail P, Gervais P, Cathelineau G. Prediction of diabetic retinopathy from color vision data. Diabetes Care 1983;6:621-2.
45. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 1988;95:693-8.
46. Mäntyjärvi M, Tuppurainen K. Could colour vision tests predict or find retinopathy in diabetic schoolchildren? Br J Ophthalmol 1995;79:711-2.
47. Bernardczyk-Meller J, Siwiec J, Kielczewska-Mrozikiewicz D, Pecold K, Korman E. [Color vision in diagnosis of early ocular changes in young patients with type 1 diabetes mellitus]. Diabetol Polska 2001;8:270-3.
48. Doucet J, Retout A, Poutrain JR, Ozenne G, Leprince MP, Parain D, et al. [A multifactorial etiologic approach to diabetic dyschromatopsia. Study of 100 diabetics]. Diabete Metab 1991;17:31-7.
49. Mecca E, Tovena G, Marchini G, Manganotti A, Marraffa M, Bonomi L. [Study of color perception using a new color test and desaturated panel D 15 in normal subjects and diabetics]. J Fr Opthalmol 1988;11:493-500.
50. Saracco JB, Gastaud P, Estachy G, Trani JC, Leid J. [Value of desaturated Panel D 15 in the detection of diabetic retinopathy]. Bull Soc Ophtalmol France 1980;80:969-73.
51. Matsuo H, Sakamoto K, Toratani Y, Ueda Y, Mikuni E, Nishimura S, et al. [The significance of color vision defects in diabetics]. J Japan Diabetol Soc 1990;33:675-80.
52. De Alwis DV. The role of automated chromatic contrast sensitivity tests in the management of diabetic retinopathy. MPhil. University of Sussex; 1994.
53. Findl O, Dallinger S, Rami B, Polak K, Schober E, Wedrich A, et al. Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes. Br J Ophthalmol 2000;84:493-8.
54. Knowles PJ, Tregear SJ, Ripley LG, Casswell AG. Colour vision in diabetic and normal pseudophakes is worse than expected. Eye 1996;10:113- 16.
55. Tregear SJ, Knowles PJ, Ripley LG, Casswell AG. Chromatic-contrast threshold impairment in diabetes. Eye 1997;11:537-46.
56. Wong R, Khan J, Adewoyin T, Sivaprasad S, Arden GB, Chong V. The ChromaTest, a digital color contrast sensitivity analyzer, for diabetic maculopathy: a pilot study. BMC Ophthalmol 2008;8:15.
57. Mirkiewicz-Sieradzka B, Zygulska-Machowa H, Romanowska B. [Evaluation of macular function in patients with diabetic retinopathy]. Klin Oczna 1986;88:209-11.
58. Sinha AK, Bhatia RP. Colour vision in diabetes mellitus. Indian J Ophthalmol 1979;27:6-8.
59. Matsuo H, Sakamoto K, Toratani Y, Ueda Y, Mikuni E, Kondo M, et al. Significance of color vision defect in patients with non-insulin-dependent diabetes (NIDDM). Diabetes Res Clin Pract 1988;5(Suppl. 1):S562.
60. Ong GL, Ripley LG, Newsom RSB, Casswell AG. Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision. Br J Ophthalmol 2003;87:747-52.
61. Davies R, Roderick P, Canning C, Brailsford S. The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med 2002;19:762-70.
62. Scotland GS, McNamee P, Philip S, Fleming AD, Goatman KA, Prescott GJ, et al. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol 2007;91:1518-23.
63. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000;320:1627-31.
64. Fenwick E, O'Brien B, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13:405-15.
65. United Kingdom National Screening Committee. Essential elements in developing a diabetic retinopathy screening programme: work book 4. August 2007. London: National Screening Programme for Diabetic Retinopathy; 2007.
66. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98(Suppl. 5):786-806.
67. Younis N, Broadbent DM, Harding SP, Vora JR. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 2002;19:1014-21.
68. Garvican L. Resources required for a local service in the national diabetic retiopathy screening programme, 2004. URL: www.retinalscreening. nhs.uk/.
69. Meller M, Karolczak-Kulesza M, Bernardczyk-Meller J. [Diagnosis and surgical treatment of idiopathic macular holes]. Klin Oczna 2001;103:39-42.
70. Hidajat RR, Hidayat JR, McLay JL, Elder MJ, Goode DH, Pointon RC. A fast system for reporting the Farnsworth-Munsell 100-hue colour vision test. Doc Ophthalmol 2004;109:109-14.
71. Odland M, Blach RK, Hamilton AM, Leaver EK, Townsend C. Photocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arc. Diabetologia 1984;26:109-15.
72. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-65.
73. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200.
74. Leese GP, Morris AD, Swaminathan K, Petrie JR, Sinharay R, Ellingford A, et al. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 2005;22:1112-15.
75. Buch HN, Barton DM, Varughese GI, Bradbury S, Scarpello JHB, Walker AB. An assessment of the coverage of a district-wide diabetic retinopathy screening service. Diabet Med 2005;22:840-1.
76. Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A. Health utility values associated with diabetic retinopathy. Diabet Med 2008;25:618-24.
77. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006;49:660-6.
78. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med 2006;23:516-21.
79. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117:1487-95.
80. Harvey JN, Craney L, Nagendran S, Ng CS. Towards comprehensive population-based screening for diabetic retinopathy: operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods. J Med Screen 2006;13:87-92.
81. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003;20:442-50.
82. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Mak 2003;23:341-50.
83. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409.
84. Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991;29:20-39.
85. Javitt JC. Cost savings associated with detection and treatment of diabetic eye disease. Pharmacoeconomics 1995;8(Suppl. 1):33-9.
86. Javitt JC, Aiello LP, Chiang Y, Ferris FL, III, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-17.
87. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. June 2008. London: National Institute for Health and Clinical Excellence; 2008.
88. National Screening Programme for Diabetic Retinopathy. English national screening programme for diabetic retinopathy. URL: www.retinalscreening.nhs.uk/pages/.
89. Virgili G, Menchini F, Dimastrogiovanni E, Rapizzi E, Menchini U, Bandello F, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthalmol Vis Sci 2007;48:4963-73.
90. Younis N, Broadbent DM, James M, Harding SP, Vora JP. Current status of screening for diabetic retinopathy in the UK. Diabet Med 2002;19(Suppl. 4):44-9.
91. Olsen JA. Improving the value of screening for diabetic macular oedema using surrogate photographic markers. URL: www.hta.ac.uk/1703.
92. Lutze M, Bresnick GH. Lenses of diabetic patients 'yellow' at an accelerated rate similar to older normals. Invest Ophthalmol Vis Sci 1991;32:194-9.
93. Beirne RO, McIlreavy L, Gore S, Zlatkova MB. Age-related lens yellowing per se contributes little to the increase in Farnsworth-Munsell 100 hue error scores with age. Ophthalmic Physiol Opt 2008;28:96.
94. Verriest G, Laethem GV, Uvijls A. A new assessment of the Farnsworth Munsell 100 Hue test scores. Am J Opthalmol 1982;93:635-42.